Taiwan · Delayed Price · Currency is TWD Lotus Pharmaceutical Statistics
Total Valuation
TPE:1795 has a market cap or net worth of TWD 49.65 billion. The enterprise value is 101.77 billion.
| Market Cap | 49.65B |
| Enterprise Value | 101.77B |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Aug 31, 2026 |
Share Statistics
TPE:1795 has 266.23 million shares outstanding. The number of shares has decreased by -0.70% in one year.
| Current Share Class | 266.23M |
| Shares Outstanding | 266.23M |
| Shares Change (YoY) | -0.70% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 0.79% |
| Owned by Institutions (%) | 12.69% |
| Float | 132.00M |
Valuation Ratios
The trailing PE ratio is 12.94 and the forward PE ratio is 8.16.
| PE Ratio | 12.94 |
| Forward PE | 8.16 |
| PS Ratio | 1.74 |
| PB Ratio | 2.04 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.78 |
| P/OCF Ratio | 11.04 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.88, with an EV/FCF ratio of 32.35.
| EV / Earnings | 27.03 |
| EV / Sales | 3.57 |
| EV / EBITDA | 10.88 |
| EV / EBIT | 13.98 |
| EV / FCF | 32.35 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 2.40.
| Current Ratio | 1.46 |
| Quick Ratio | 0.88 |
| Debt / Equity | 2.40 |
| Debt / EBITDA | 6.25 |
| Debt / FCF | 18.58 |
| Interest Coverage | 2.40 |
Financial Efficiency
Return on equity (ROE) is 16.86% and return on invested capital (ROIC) is 7.47%.
| Return on Equity (ROE) | 16.86% |
| Return on Assets (ROA) | 6.20% |
| Return on Invested Capital (ROIC) | 7.47% |
| Return on Capital Employed (ROCE) | 8.00% |
| Weighted Average Cost of Capital (WACC) | 5.74% |
| Revenue Per Employee | 25.92M |
| Profits Per Employee | 3.43M |
| Employee Count | 1,099 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.06 |
Taxes
In the past 12 months, TPE:1795 has paid 1.10 billion in taxes.
| Income Tax | 1.10B |
| Effective Tax Rate | 22.59% |
Stock Price Statistics
The stock price has decreased by -3.87% in the last 52 weeks. The beta is 0.64, so TPE:1795's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -3.87% |
| 50-Day Moving Average | 190.97 |
| 200-Day Moving Average | 245.63 |
| Relative Strength Index (RSI) | 48.57 |
| Average Volume (20 Days) | 1,371,196 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:1795 had revenue of TWD 28.49 billion and earned 3.77 billion in profits. Earnings per share was 14.41.
| Revenue | 28.49B |
| Gross Profit | 15.31B |
| Operating Income | 7.28B |
| Pretax Income | 4.86B |
| Net Income | 3.77B |
| EBITDA | 9.20B |
| EBIT | 7.28B |
| Earnings Per Share (EPS) | 14.41 |
Balance Sheet
The company has 6.33 billion in cash and 58.45 billion in debt, with a net cash position of -52.12 billion or -195.78 per share.
| Cash & Cash Equivalents | 6.33B |
| Total Debt | 58.45B |
| Net Cash | -52.12B |
| Net Cash Per Share | -195.78 |
| Equity (Book Value) | 24.31B |
| Book Value Per Share | 91.30 |
| Working Capital | 8.14B |
Cash Flow
In the last 12 months, operating cash flow was 4.50 billion and capital expenditures -1.35 billion, giving a free cash flow of 3.15 billion.
| Operating Cash Flow | 4.50B |
| Capital Expenditures | -1.35B |
| Depreciation & Amortization | 1.92B |
| Net Borrowing | 12.64B |
| Free Cash Flow | 3.15B |
| FCF Per Share | 11.82 |
Margins
Gross margin is 53.75%, with operating and profit margins of 25.56% and 13.22%.
| Gross Margin | 53.75% |
| Operating Margin | 25.56% |
| Pretax Margin | 17.08% |
| Profit Margin | 13.22% |
| EBITDA Margin | 32.30% |
| EBIT Margin | 25.56% |
| FCF Margin | 11.04% |
Dividends & Yields
This stock pays an annual dividend of 2.56, which amounts to a dividend yield of 1.39%.
| Dividend Per Share | 2.56 |
| Dividend Yield | 1.39% |
| Dividend Growth (YoY) | -55.61% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 40.35% |
| Buyback Yield | 0.70% |
| Shareholder Yield | 2.09% |
| Earnings Yield | 7.58% |
| FCF Yield | 6.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for TPE:1795 is 334.00, which is 79.09% higher than the current price. The consensus rating is "Buy".
| Price Target | 334.00 |
| Price Target Difference | 79.09% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | -1.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPE:1795 has an Altman Z-Score of 1.24 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.24 |
| Piotroski F-Score | 4 |